Holding plenty of cheap stock from last year and have had plenty of fun with covered calls and selling puts. I think that it’s a good company that is still in the growth phase. Ups and downs have mostly been about their compounded weight loss copy cat treatments and whether they would be sued by Nova Nordisk or Eli Lilly. Reality is that cheap dick pills (that work) in the mail was a market ripe for the plucking, and they still might end up as an acquisition target, e.g. Amazon.

---